Nuwellis, Inc. SEC filings NUWE

Nuwellis, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jan 28, 2013. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (change to shareholder rights, bylaw or fiscal year change). The company's fiscal year ends on December 31.

Nuwellis, Inc. SEC filings
Form Description Filed Period
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Oct 23, 2026 Oct 22, 2026
EFFECT Filing Aug 26, 2026 —
424B3 Prospectus Aug 26, 2026 —
8-K Current report
Regulation FD disclosure
Aug 26, 2026 Aug 25, 2026
S-3 Shelf registration Aug 18, 2026 —
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 3, 2026 Jul 31, 2026
424B5 Prospectus supplement Aug 3, 2026 —
8-K Current report
Shareholder vote results
Jul 24, 2026 Jul 24, 2026
DEF 14A Proxy statement Jul 7, 2026 Jul 7, 2026
PRE 14A Preliminary proxy statement Jun 26, 2026 Jul 24, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jun 24, 2026 Jun 23, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 18, 2026 Jun 16, 2026
8-K Current report
Regulation FD disclosure
Jun 10, 2026 Jun 8, 2026
424B4 Prospectus Jun 8, 2026 —
S-1MEF Filing Jun 5, 2026 —
EFFECT Filing Jun 4, 2026 —
CORRESP Letter to the SEC Jun 4, 2026 —
S-1/A Amended registration statement Jun 4, 2026 —
FWP Free writing prospectus Jun 2, 2026 —
S-1/A Amended registration statement May 29, 2026 —
SD Specialized disclosure (conflict minerals) May 28, 2026 —
S-1 Registration statement May 22, 2026 —
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
8-K Current report
Shareholder vote results
Apr 29, 2026 Apr 28, 2026
8-K Current report
Other events
Apr 24, 2026 Apr 24, 2026
DEFA14A Additional proxy material Apr 6, 2026 —
ARS Annual report to shareholders Apr 2, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 2, 2026 Apr 28, 2026
8-K/A Amended current report
Officer or director change
Apr 1, 2026 Mar 26, 2026
8-K Current report
Officer or director change
Mar 27, 2026 Mar 26, 2026
8-K Current report
Other events
Mar 17, 2026 Mar 17, 2026
10-K Annual report Mar 11, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 10, 2026 Mar 10, 2026
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Feb 26, 2026 Feb 24, 2026
EFFECT Filing Feb 9, 2026 —
424B3 Prospectus Feb 9, 2026 —
CORRESP Letter to the SEC Feb 6, 2026 —
UPLOAD Letter from the SEC Feb 5, 2026 —
S-3 Shelf registration Feb 4, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Officer or director change, Regulation FD disclosure
Jan 30, 2026 Jan 29, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 23, 2026 Jan 21, 2026
DRS Filing Nov 25, 2025 —
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
8-K Current report
Officer or director change
Oct 8, 2025 Oct 7, 2025
8-K Current report
Other events
Sep 30, 2025 Sep 30, 2025
8-K Current report
Other events
Sep 18, 2025 Sep 18, 2025
8-K Current report
Other events
Sep 9, 2025 Sep 9, 2025
8-K Current report
Material agreement
Sep 3, 2025 Sep 3, 2025
424B5 Prospectus supplement Sep 3, 2025 —
8-K Current report
Other events
Aug 21, 2025 Aug 21, 2025
8-K Current report
Other events
Aug 19, 2025 Aug 19, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
8-K Current report
Shareholder vote results
Aug 4, 2025 Aug 4, 2025
8-K Current report
Other events
Jul 23, 2025 Jul 22, 2025
DEF 14A Proxy statement Jul 14, 2025 Aug 4, 2025
PRE 14A Preliminary proxy statement Jul 3, 2025 Aug 4, 2025
8-K Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
Jul 2, 2025 Jun 27, 2025
8-K Current report
Listing notice
Jun 23, 2025 Jun 18, 2025
424B4 Prospectus Jun 10, 2025 —
EFFECT Filing Jun 9, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
Jun 9, 2025 Jun 6, 2025
CORRESP Letter to the SEC Jun 5, 2025 —
CORRESP Letter to the SEC Jun 5, 2025 —
S-1/A Amended registration statement Jun 3, 2025 —
S-1 Registration statement May 30, 2025 —
SD Specialized disclosure (conflict minerals) May 29, 2025 —
8-K Current report
Shareholder vote results
May 22, 2025 May 20, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
8-K Current report
Material agreement
May 12, 2025 May 9, 2025
DEFR14A Filing May 9, 2025 —
UPLOAD Letter from the SEC Apr 17, 2025 —
ARS Annual report to shareholders Apr 14, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 14, 2025 May 20, 2025
DRS Filing Apr 11, 2025 —
8-K Current report
Regulation FD disclosure
Apr 3, 2025 Apr 3, 2025
PRE 14A Preliminary proxy statement Apr 1, 2025 May 20, 2025
10-K Annual report Mar 11, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 11, 2025 Mar 11, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 24, 2025 Feb 18, 2025
EFFECT Filing Dec 20, 2024 —
424B3 Prospectus Dec 20, 2024 —
CORRESP Letter to the SEC Dec 20, 2024 —
S-1/A Amended registration statement Dec 19, 2024 —
8-K Current report
Other events
Dec 19, 2024 Dec 17, 2024
8-K Current report
Other events
Dec 16, 2024 Dec 16, 2024
UPLOAD Letter from the SEC Nov 22, 2024 —
D Filing Nov 20, 2024 —
S-1 Registration statement Nov 15, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 11, 2024
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
Nov 7, 2024 Nov 5, 2024
8-K Current report
Results of operations
Nov 1, 2024 Nov 1, 2024
8-K Current report
Agreement ended
Oct 23, 2024 Oct 20, 2024
EFFECT Filing Sep 6, 2024 —
424B3 Prospectus Sep 6, 2024 —
CORRESP Letter to the SEC Sep 4, 2024 —
D Filing Sep 4, 2024 —
S-1/A Amended registration statement Aug 29, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Aug 26, 2024 Aug 23, 2024
424B5 Prospectus supplement Aug 26, 2024 —
8-K Current report
Agreement ended
Aug 22, 2024 Aug 21, 2024
UPLOAD Letter from the SEC Aug 21, 2024 —
S-1 Registration statement Aug 15, 2024 —
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
8-K Current report
Listing notice
Aug 12, 2024 Aug 8, 2024
D Filing Aug 2, 2024 —
424B5 Prospectus supplement Jul 25, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jul 25, 2024 Jul 24, 2024
8-K/A Amended current report
Other events
Jul 17, 2024 Jul 16, 2024
8-K Current report
Regulation FD disclosure, Other events
Jul 17, 2024 Jul 17, 2024
8-K Current report
Other events
Jul 17, 2024 Jul 16, 2024
EFFECT Filing Jul 9, 2024 —
CORRESP Letter to the SEC Jul 8, 2024 —
UPLOAD Letter from the SEC Jul 8, 2024 —
8-K Current report
Agreement ended
Jul 3, 2024 Jul 1, 2024
S-3 Shelf registration Jul 1, 2024 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Jun 26, 2024 Jun 26, 2024
8-K Current report
Listing notice, Shareholder vote results
Jun 10, 2024 Jun 5, 2024
8-K Current report
Material agreement, Other events
Jun 6, 2024 May 31, 2024
8-K Current report
Listing notice, Other events
May 29, 2024 May 23, 2024
SD Specialized disclosure (conflict minerals) May 29, 2024 —
ARS Annual report to shareholders May 17, 2024 Dec 31, 2023
DEFR14A Filing May 17, 2024 —
10-Q Quarterly report May 8, 2024 Mar 31, 2024
PRER14A Filing May 8, 2024 —
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
DEF 14A Proxy statement May 1, 2024 Jun 6, 2024
8-K Current report
Material agreement, Other events
May 1, 2024 Apr 26, 2024
424B4 Prospectus Apr 29, 2024 —
EFFECT Filing Apr 26, 2024 —
CORRESP Letter to the SEC Apr 22, 2024 —
CORRESP Letter to the SEC Apr 22, 2024 —
CORRESP Letter to the SEC Apr 22, 2024 —
CORRESP Letter to the SEC Apr 22, 2024 —
CORRESP Letter to the SEC Apr 17, 2024 —
CORRESP Letter to the SEC Apr 17, 2024 —
S-1/A Amended registration statement Apr 17, 2024 —
PRE 14A Preliminary proxy statement Apr 9, 2024 May 10, 2024
8-K Current report
Other events
Mar 26, 2024 Mar 26, 2024
S-1/A Amended registration statement Mar 13, 2024 —
10-K Annual report Mar 11, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 6, 2024 Mar 5, 2024
CORRESP Letter to the SEC Feb 14, 2024 —
CORRESP Letter to the SEC Feb 14, 2024 —
CORRESP Letter to the SEC Feb 9, 2024 —
CORRESP Letter to the SEC Feb 9, 2024 —
S-1/A Amended registration statement Feb 8, 2024 —
8-K Current report
Other events
Feb 6, 2024 Feb 6, 2024
S-1/A Amended registration statement Feb 5, 2024 —
S-1/A Amended registration statement Jan 31, 2024 —
UPLOAD Letter from the SEC Jan 26, 2024 —
S-1 Registration statement Jan 18, 2024 —
8-K/A Amended current report
Regulation FD disclosure
Jan 9, 2024 Jan 9, 2024
8-K Current report
Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
8-K Current report
Listing notice
Dec 13, 2023 Dec 7, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Officer or director change
Nov 1, 2023 Oct 30, 2023
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
Oct 17, 2023 Oct 12, 2023
424B4 Prospectus Oct 16, 2023 —
8-K Current report
Other events
Oct 10, 2023 Oct 10, 2023
POS462C Form pos462c Oct 6, 2023 —
AW Filing Oct 5, 2023 —
POS AM Filing Oct 4, 2023 —
EFFECT Filing Sep 29, 2023 —
CORRESP Letter to the SEC Sep 29, 2023 —
CORRESP Letter to the SEC Sep 29, 2023 —
S-1/A Amended registration statement Sep 29, 2023 —
UPLOAD Letter from the SEC Sep 27, 2023 —
S-1 Registration statement Sep 21, 2023 —
8-K Current report
Officer or director change
Aug 18, 2023 Aug 15, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 8, 2023 Aug 4, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
D Filing Jun 26, 2023 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jun 21, 2023 Jun 19, 2023
8-K Current report
Officer or director change
Jun 5, 2023 May 30, 2023
SD Specialized disclosure (conflict minerals) May 25, 2023 —
8-K Current report
Shareholder vote results
May 22, 2023 May 19, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
ARS Annual report to shareholders Apr 7, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 7, 2023 —
8-K Current report
Regulation FD disclosure
Mar 14, 2023 Mar 14, 2023
424B5 Prospectus supplement Mar 3, 2023 —
10-K Annual report Mar 3, 2023 Dec 31, 2022
8-K Current report
Results of operations, Other events
Mar 1, 2023 Feb 23, 2023
8-K Current report
Officer or director change
Jan 18, 2023 Jan 16, 2023
8-K Current report
Results of operations
Jan 9, 2023 Jan 9, 2023
8-K Current report
Shareholder vote results
Jan 5, 2023 Jan 4, 2023
8-K Current report
Material agreement
Dec 29, 2022 Dec 27, 2022
DEFA14A Additional proxy material Dec 28, 2022 —
8-K Current report
Other events
Dec 27, 2022 Dec 27, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
NUWE (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Eden Prairie, MN
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1506492
Former names
CHF Solutions, Inc. (until Apr 16, 2021); Sunshine Heart, Inc. (until May 23, 2017)

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.